TFRC and familial dilated cardiomyopathy: In DCM pathogenesis, active inflammation and persistent immune activation may reduce the levels of Tfr; then, Tfh and germinal center B cell proliferation and activation are out of control, as well as the production of related antibodies, which accelerates myocardial injury in patients with DCM (20).